Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075381

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2075381

Procalcitonin Antibody Market, By Antibody Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 250+ Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Procalcitonin Antibody Market is estimated to be valued at USD 273.5 million in 2026 and is expected to reach USD 512.9 million by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 273.5 million
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.40% 2033 Value Projection: USD 512.9 million

The global procalcitonin antibody market covers a broad set of antibody type categories, including Monoclonal Procalcitonin Antibodies, Polyclonal Procalcitonin Antibodies, and Recombinant Procalcitonin Antibodies, used across applications such as Clinical Diagnostics, Research Laboratories, and Pharmaceutical Development. Demand is supported by adoption among Hospitals, and Diagnostic Laboratories and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Clinical Diagnostics, and Research Laboratories, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global procalcitonin antibody market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Diagnostic Laboratories. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global procalcitonin antibody market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, Abcam plc, Sino Biological Inc., Agilent Technologies Inc., Abnova Corporation, Santa Cruz Biotechnology Inc., Fitzgerald Industries International, and HyTest Ltd, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global procalcitonin antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global procalcitonin antibody market.

Detailed Segmentation:

  • Global Procalcitonin Antibody Market, By Antibody Type (Revenue, USD Mn, 2021 - 2033)
  • Monoclonal Procalcitonin Antibodies
  • Polyclonal Procalcitonin Antibodies
  • Recombinant Procalcitonin Antibodies
  • Others
  • Global Procalcitonin Antibody Market, By Application (Revenue, USD Mn, 2021 - 2033)
  • Clinical Diagnostics
  • Research Laboratories
  • Pharmaceutical Development
  • Others
  • Global Procalcitonin Antibody Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Biotechnology Companies
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • Bio-Rad Laboratories*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Thermo Fisher Scientific
  • Merck KGaA
  • Abcam plc
  • Sino Biological Inc.
  • Agilent Technologies Inc.
  • Abnova Corporation
  • Santa Cruz Biotechnology Inc.
  • Fitzgerald Industries International
  • HyTest Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI1907

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Preview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Antibody Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis
  • Partnership Scenario
  • Brand and Pricing Analysis
  • Distributors Landscape
  • Porters Analysis
  • Technological Advancements
  • Key Developments
  • Market Trend
  • Future Prospective
  • Top Market Players by Revenue

4. Procalcitonin Antibody Market By Antibody Type, 2026-2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Monoclonal Procalcitonin Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Polyclonal Procalcitonin Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Recombinant Procalcitonin Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

5. Procalcitonin Antibody Market By Application, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Pharmaceutical Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

6. Procalcitonin Antibody Market By End User, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)

7. Procalcitonin Antibody Market By Region, 2026 - 2033, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Benelux
      • Denmark
      • Norway
      • Sweden
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
      • China
      • Taiwan
      • India
      • Japan
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
  • Bahrain
  • Kuwait
  • Oman
  • Qatar
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of the Middle East

1. Competitive Landscape

  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abcam plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sino Biological Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abnova Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Santa Cruz Biotechnology Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fitzgerald Industries International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • HyTest Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

2. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!